Synchron pauses trial of its second-generation Stentrode brain implant
Synchron has paused clinical trials of its second-generation Stentrode device due to signal lead issues, while restructuring the company and...
Synchron has paused clinical trials of its second-generation Stentrode device due to signal lead issues, while restructuring the company and...